Cancer cells often develop resistance to traditional therapies, and the non-specific nature of these treatments can damage healthy tissues. Enhanced drug delivery systems aim to overcome these issues by ensuring that higher concentrations of the drug reach the tumor site while sparing normal tissues. This approach not only increases the effectiveness of the treatment but also reduces side effects, improving patient quality of life.
